Senores Pharmaceuticals schedules analyst meet on June 9

0 min read     Updated on 04 Jun 2026, 03:54 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Senores Pharmaceuticals has announced an analyst and institutional investor meeting scheduled for June 9, 2026, in Mumbai. Hosted by Macquarie, the physical group meeting will be held from 1:30 PM to 2:30 PM IST.

powered bylight_fuzz_icon
42114267

*this image is generated using AI for illustrative purposes only.

senores pharmaceuticals has scheduled an analyst and institutional investor meeting on June 9, 2026. The meeting is intended to engage with market analysts and institutional investors to discuss the company's performance and outlook.

The session will be hosted by Macquarie and will take place in Mumbai. It is scheduled as a physical group meeting, providing a platform for direct interaction between the company's management and investors.

The meeting is set to occur from 1:30 PM to 2:30 PM IST. This initiative follows the disclosure requirements under Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (SEBI) regulations.

Meeting Details

Date & Time Host Nature of Meeting Place Mode
June 9, 2026
01:30 PM to 02:30 PM IST
Macquarie Group Meeting Mumbai Physical

Historical Stock Returns for Senores Pharmaceuticals

1 Day5 Days1 Month6 Months1 Year5 Years
-0.07%-6.19%+16.15%+32.95%+100.75%+87.49%

What key strategic updates or guidance is Senores Pharmaceuticals likely to share during the meeting?

How might the meeting influence investor sentiment and the company's stock performance?

What are the expected topics of discussion regarding the company's future growth prospects?

Senores Pharmaceuticals
View Company Insights
View All News
like17
dislike

Senores Pharma to hold investor meet on May 28

0 min read     Updated on 23 May 2026, 09:09 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Senores Pharmaceuticals Limited announced an investor conference scheduled for May 28, 2026, in Mumbai. Hosted by 360 One Capital, the meeting targets analysts and institutional investors to discuss publicly available information without sharing unpublished price sensitive information.

powered bylight_fuzz_icon
40803778

*this image is generated using AI for illustrative purposes only.

Senores Pharmaceuticals Limited has announced that its officials will attend an investor conference scheduled for May 28, 2026. The meeting is being conducted pursuant to Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Details

The interaction is aimed at analysts and institutional investors. The company has specified that the discussions will be based solely on publicly available information. It explicitly stated that no unpublished price sensitive information (UPSI) is intended to be discussed during these interactions.

The schedule for the meeting is as follows:

Date & Time Hosted by Nature of Meeting Place Mode of Meeting
28th May, 2026
10:00 A.M. (IST)
onwards
360 One Capital Group / 1x1 Meetings Mumbai Physical

Additional Information

The company noted that changes to the schedule may occur due to exigencies on the part of the host or the company. The disclosure was made by Vinay Kumar Mishra, Company Secretary and Compliance Officer.

Historical Stock Returns for Senores Pharmaceuticals

1 Day5 Days1 Month6 Months1 Year5 Years
-0.07%-6.19%+16.15%+32.95%+100.75%+87.49%

What strategic updates or business milestones might Senores Pharmaceuticals be positioning to highlight to institutional investors at this conference?

How has Senores Pharmaceuticals' stock performance and institutional investor interest trended leading up to this investor engagement?

Could this investor conference signal upcoming capital raising activities, partnerships, or expansion plans for Senores Pharmaceuticals?

Senores Pharmaceuticals
View Company Insights
View All News
like20
dislike

More News on Senores Pharmaceuticals

1 Year Returns:+100.75%